RUS  ENG
Full version
PEOPLE

Stroylov Viktor Sergeevich

Publications in Math-Net.Ru

  1. Substituted cinnamides: Characterization of non-toxic inhibitors of alpha-synuclein aggregation

    Mendeleev Commun., 33:3 (2023),  334–336
  2. Preliminary modelling as the first stage of targeted organic synthesis

    Usp. Khim., 90:7 (2021),  831–867
  3. Modeling of novel CDK7 inhibitors activity by molecular dynamics and free energy perturbation methods

    Mendeleev Commun., 30:4 (2020),  430–432
  4. Computational identification of disulfiram and neratinib as putative SARS-CoV-2 main protease inhibitors

    Mendeleev Commun., 30:4 (2020),  419–420
  5. Molecular foundations of COVID-19 pathogenesis

    Usp. Khim., 89:8 (2020),  858–878
  6. Cinnamic acid derivatives as the potential modulators of prion aggregation

    Mendeleev Commun., 27:5 (2017),  493–494
  7. Modeling comparative selectivity profiles of kinase inhibitors using FEP/MD protocol

    Mendeleev Commun., 27:4 (2017),  349–351
  8. Novel PARP1 inhibitors potentiate doxorubicin antitumor activity in vitro

    Mendeleev Commun., 25:5 (2015),  364–366
  9. Modeling of the Diels–Alder reaction enantioselectivity by quantum mechanics and molecular mechanics

    Mendeleev Commun., 25:4 (2015),  269–270
  10. Efficacy of Novel Syk-Kinase Inhibitors MT-SYK-03 and MT-SYK-322 in Cellular Models of Autoimmunity and Cancer

    Mendeleev Commun., 22:6 (2012),  287–289
  11. Rational design and synthesis of novel Syk-kinase inhibitors

    Mendeleev Commun., 22:2 (2012),  73–74
  12. Rational design and synthesis of new PARP1 inhibitors

    Mendeleev Commun., 22:1 (2012),  15–17
  13. Novel fragment-like inhibitors of EphA2 obtained by experimental screening and modelling

    Mendeleev Commun., 20:5 (2010),  263–265


© Steklov Math. Inst. of RAS, 2026